Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiongated channel activity

KCND3 PIEZO1 TMC8 TMEM63C HTR3B RYR1 CHRNB3 RYR2

1.39e-05334668GO:0022836
GeneOntologyMolecularFunctionmonoatomic cation channel activity

KCND3 PIEZO1 SCN8A TMEM63C HTR3B RYR1 CHRNB3 RYR2

1.69e-05343668GO:0005261
GeneOntologyMolecularFunctionmonoatomic ion channel activity

KCND3 PIEZO1 SCN8A TMC8 TMEM63C HTR3B RYR1 CHRNB3 RYR2

1.92e-05459669GO:0005216
GeneOntologyMolecularFunction1-acylglycerol-3-phosphate O-acyltransferase activity

AGPAT5 MBOAT7 GPAT4

4.40e-0521663GO:0003841
GeneOntologyMolecularFunctionchannel activity

KCND3 PIEZO1 SCN8A TMC8 TMEM63C HTR3B RYR1 CHRNB3 RYR2

5.47e-05525669GO:0015267
GeneOntologyMolecularFunctionpassive transmembrane transporter activity

KCND3 PIEZO1 SCN8A TMC8 TMEM63C HTR3B RYR1 CHRNB3 RYR2

5.56e-05526669GO:0022803
GeneOntologyMolecularFunctionryanodine-sensitive calcium-release channel activity

RYR1 RYR2

6.43e-054662GO:0005219
GeneOntologyMolecularFunctiontransporter activity

ABCG4 KCND3 PIEZO1 SCN8A TMC8 TMEM63C SLC15A5 ATP9B HTR3B STRA6 SLC36A2 RYR1 CHRNB3 RYR2

6.61e-0512896614GO:0005215
GeneOntologyMolecularFunctionlysophosphatidic acid acyltransferase activity

AGPAT5 MBOAT7 GPAT4

6.64e-0524663GO:0042171
GeneOntologyMolecularFunctionlysophospholipid acyltransferase activity

AGPAT5 MBOAT7 GPAT4

6.64e-0524663GO:0071617
GeneOntologyMolecularFunctionligand-gated monoatomic cation channel activity

TMEM63C HTR3B RYR1 CHRNB3 RYR2

1.00e-04140665GO:0099094
GeneOntologyMolecularFunctiontransmembrane transporter activity

ABCG4 KCND3 PIEZO1 SCN8A TMC8 TMEM63C SLC15A5 HTR3B STRA6 SLC36A2 RYR1 CHRNB3 RYR2

1.09e-0411806613GO:0022857
GeneOntologyMolecularFunctionacylglycerol O-acyltransferase activity

AGPAT5 MBOAT7 GPAT4

1.60e-0432663GO:0016411
GeneOntologyMolecularFunctioncalcium-induced calcium release activity

RYR1 RYR2

1.60e-046662GO:0048763
GeneOntologyMolecularFunctionmonoatomic ion transmembrane transporter activity

KCND3 PIEZO1 SCN8A TMC8 TMEM63C HTR3B SLC36A2 RYR1 CHRNB3 RYR2

2.59e-047936610GO:0015075
GeneOntologyMolecularFunctionmonoatomic cation transmembrane transporter activity

KCND3 PIEZO1 SCN8A TMEM63C HTR3B SLC36A2 RYR1 CHRNB3 RYR2

3.21e-04664669GO:0008324
GeneOntologyMolecularFunctionglycosyltransferase activity

TMTC1 PIGA UGT2B15 UGT2B17 B4GALT5 TIPARP

3.76e-04288666GO:0016757
GeneOntologyMolecularFunctionligand-gated monoatomic ion channel activity

TMEM63C HTR3B RYR1 CHRNB3 RYR2

4.44e-04193665GO:0015276
GeneOntologyMolecularFunctionligand-gated channel activity

TMEM63C HTR3B RYR1 CHRNB3 RYR2

4.87e-04197665GO:0022834
GeneOntologyMolecularFunctionretinoid binding

UGT2B15 UGT2B17 STRA6

5.36e-0448663GO:0005501
GeneOntologyMolecularFunctionisoprenoid binding

UGT2B15 UGT2B17 STRA6

5.70e-0449663GO:0019840
GeneOntologyMolecularFunctionhexosyltransferase activity

TMTC1 PIGA UGT2B15 UGT2B17 B4GALT5

6.65e-04211665GO:0016758
GeneOntologyMolecularFunctionO-acyltransferase activity

AGPAT5 MBOAT7 GPAT4

9.82e-0459663GO:0008374
GeneOntologyMolecularFunctiontransmembrane signaling receptor activity

VIPR1 CXCR3 OR2AK2 KISS1R GPR158 IL17RE TMEM63C OR1K1 FCRLA HTR3B OR4K15 CHRNB3

1.44e-0313536612GO:0004888
GeneOntologyMolecularFunctionmechanosensitive monoatomic ion channel activity

PIEZO1 TMC8

1.59e-0318662GO:0008381
GeneOntologyMolecularFunctionintracellularly gated calcium channel activity

RYR1 RYR2

1.59e-0318662GO:0015278
GeneOntologyMolecularFunctionUDP-glycosyltransferase activity

PIGA UGT2B15 UGT2B17 B4GALT5

1.65e-03153664GO:0008194
GeneOntologyMolecularFunctionretinoic acid binding

UGT2B15 UGT2B17

3.85e-0328662GO:0001972
GeneOntologyMolecularFunctionneurotransmitter receptor activity

GPR158 HTR3B CHRNB3

4.44e-03100663GO:0030594
GeneOntologyBiologicalProcessestrogen metabolic process

UGT2B15 UGT2B17 HSD17B1 TIPARP

2.31e-0552664GO:0008210
GeneOntologyCellularComponentendoplasmic reticulum membrane

TMX2 ESYT2 PIGA AGPAT5 RETREG2 SBF1 MBOAT7 WFS1 PIEZO1 TMC8 UGT2B15 UGT2B17 TMEM39A GPAT4 SLC36A2 RYR1 RYR2 PROS1

1.03e-0712936818GO:0005789
GeneOntologyCellularComponentendoplasmic reticulum subcompartment

TMX2 ESYT2 PIGA AGPAT5 RETREG2 SBF1 MBOAT7 WFS1 PIEZO1 TMC8 UGT2B15 UGT2B17 TMEM39A GPAT4 SLC36A2 RYR1 RYR2 PROS1

1.10e-0712996818GO:0098827
GeneOntologyCellularComponentnuclear outer membrane-endoplasmic reticulum membrane network

TMX2 ESYT2 PIGA AGPAT5 RETREG2 SBF1 MBOAT7 WFS1 PIEZO1 TMC8 UGT2B15 UGT2B17 TMEM39A GPAT4 SLC36A2 RYR1 RYR2 PROS1

1.52e-0713276818GO:0042175
GeneOntologyCellularComponentjunctional sarcoplasmic reticulum membrane

RYR1 RYR2

4.61e-0410682GO:0014701
GeneOntologyCellularComponentorganelle membrane contact site

TMX2 ESYT2 MBOAT7

8.50e-0457683GO:0044232
GeneOntologyCellularComponentcation channel complex

KCND3 SCN8A HTR3B RYR1 RYR2

1.01e-03235685GO:0034703
GeneOntologyCellularComponentmonoatomic ion channel complex

KCND3 SCN8A HTR3B RYR1 CHRNB3 RYR2

1.43e-03378686GO:0034702
DomainRyanrecept_TM4-6

RYR1 RYR2

3.68e-053662IPR009460
DomainRyR

RYR1 RYR2

3.68e-053662PF02026
DomainRyanodine_rcpt

RYR1 RYR2

3.68e-053662IPR003032
DomainRR_TM4-6

RYR1 RYR2

3.68e-053662PF06459
DomainRyan_recept

RYR1 RYR2

3.68e-053662IPR013333
DomainRIH_assoc

RYR1 RYR2

1.83e-046662PF08454
DomainRIH_assoc-dom

RYR1 RYR2

1.83e-046662IPR013662
DomainRIH_dom

RYR1 RYR2

1.83e-046662IPR000699
DomainIns145_P3_rcpt

RYR1 RYR2

1.83e-046662IPR014821
DomainRyanodine_recept-rel

RYR1 RYR2

1.83e-046662IPR015925
Domain-

RYR1 RYR2

1.83e-0466621.25.10.30
DomainRYDR_ITPR

RYR1 RYR2

1.83e-046662PF01365
DomainIns145_P3_rec

RYR1 RYR2

1.83e-046662PF08709
DomainMIR

RYR1 RYR2

5.43e-0410662PS50919
DomainMIR

RYR1 RYR2

5.43e-0410662PF02815
DomainMIR

RYR1 RYR2

5.43e-0410662SM00472
DomainMIR_motif

RYR1 RYR2

5.43e-0410662IPR016093
DomainIon_trans_dom

KCND3 SCN8A RYR1 RYR2

7.09e-04114664IPR005821
DomainIon_trans

KCND3 SCN8A RYR1 RYR2

7.09e-04114664PF00520
DomainAcyltransferase

AGPAT5 GPAT4

1.43e-0316662PF01553
DomainPlsC

AGPAT5 GPAT4

1.62e-0317662SM00563
DomainPlipid/glycerol_acylTrfase

AGPAT5 GPAT4

1.62e-0317662IPR002123
DomainIQ

SCN8A CAMTA2 UBE3C

2.03e-0371663PF00612
DomainUDPGT

UGT2B15 UGT2B17

2.47e-0321662PF00201
DomainUDPGT

UGT2B15 UGT2B17

2.47e-0321662PS00375
DomainUDP_glucos_trans

UGT2B15 UGT2B17

2.47e-0321662IPR002213
DomainIQ

SCN8A CAMTA2 UBE3C

2.95e-0381663SM00015
Domain-

HTR3B CHRNB3

2.97e-03236621.20.120.370
DomainAcetylcholine_rcpt_TM

HTR3B CHRNB3

2.97e-0323662IPR027361
DomainIQ_motif_EF-hand-BS

SCN8A CAMTA2 UBE3C

3.98e-0390663IPR000048
DomainHECT

HECW2 UBE3C

4.08e-0327662PF00632
DomainHECTc

HECW2 UBE3C

4.08e-0327662SM00119
DomainHECT_dom

HECW2 UBE3C

4.08e-0327662IPR000569
DomainHECT

HECW2 UBE3C

4.08e-0327662PS50237
DomainIQ

SCN8A CAMTA2 UBE3C

4.36e-0393663PS50096
DomainEF-hand_8

RYR1 RYR2

6.41e-0334662PF13833
Pubmed

Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells.

UGT2B15 UGT2B17

3.77e-06268232660355
Pubmed

Skeletal and cardiac ryanodine receptors exhibit different responses to Ca2+ overload and luminal ca2+.

RYR1 RYR2

3.77e-06268217259277
Pubmed

Ryanodine receptor oligomeric interaction: identification of a putative binding region.

RYR1 RYR2

3.77e-06268214722100
Pubmed

The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence.

UGT2B15 UGT2B17

3.77e-0626821909870
Pubmed

Structural and functional interactions within ryanodine receptor.

RYR1 RYR2

3.77e-06268226009179
Pubmed

Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.

UGT2B15 UGT2B17

3.77e-06268224121496
Pubmed

Structure and Function of the Human Ryanodine Receptors and Their Association with Myopathies-Present State, Challenges, and Perspectives.

RYR1 RYR2

3.77e-06268232899693
Pubmed

Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation.

UGT2B15 UGT2B17

3.77e-0626823117546
Pubmed

Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.

UGT2B15 UGT2B17

3.77e-06268224267955
Pubmed

Recent advances in understanding the ryanodine receptor calcium release channels and their role in calcium signalling.

RYR1 RYR2

3.77e-06268230542613
Pubmed

Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.

UGT2B15 UGT2B17

3.77e-06268222170718
Pubmed

Localization and phenotype-specific expression of ryanodine calcium release channels in C57BL6 and DBA/2J mouse strains.

GPNMB RYR1

3.77e-06268221933672
Pubmed

Ryanodine receptors are expressed and functionally active in mouse spermatogenic cells and their inhibition interferes with spermatogonial differentiation.

RYR1 RYR2

3.77e-06268215280431
Pubmed

Expression of the ryanodine receptor isoforms in immune cells.

RYR1 RYR2

3.77e-06268211673493
Pubmed

B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators.

RYR1 RYR2

3.77e-06268211673462
Pubmed

Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5.

UGT2B15 UGT2B17

3.77e-0626823105095
Pubmed

UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.

UGT2B15 UGT2B17

3.77e-06268217848572
Pubmed

Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain.

RYR1 RYR2

3.77e-06268225370123
Pubmed

Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.

UGT2B15 UGT2B17

3.77e-06268227496708
Pubmed

Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion.

RYR1 RYR2

3.77e-06268215033925
Pubmed

Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation.

UGT2B15 UGT2B17

3.77e-06268228228532
Pubmed

Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels.

RYR1 RYR2

3.77e-06268218618700
Pubmed

Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium.

UGT2B15 UGT2B17

3.77e-06268215666817
Pubmed

The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.

UGT2B15 UGT2B17

3.77e-06268217698910
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

SBF1 IL17RE KLHL21 PIEZO1 SCN8A TSC2 UBE3C ARHGAP35 SNAPC4 GPAT4 RYR1

9.26e-061105681135748872
Pubmed

Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.

RYR1 RYR2

1.13e-05368218403125
Pubmed

Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.

UGT2B15 UGT2B17

1.13e-05368219572376
Pubmed

Circ_0057583 facilitates brain microvascular endothelial cell injury through modulating miR-204-5p/NR4A1 axis.

HECW2 NR4A1

1.13e-05368234767155
Pubmed

Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis model.

TSC2 GPNMB

1.13e-05368226880751
Pubmed

Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.

RYR1 RYR2

1.13e-05368218434746
Pubmed

Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines.

UGT2B15 UGT2B17

1.13e-05368226163549
Pubmed

Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells.

UGT2B15 UGT2B17

1.13e-05368220736324
Pubmed

SPRY domains in ryanodine receptors (Ca(2+)-release channels).

RYR1 RYR2

1.13e-0536829204703
Pubmed

The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.

RYR1 RYR2

1.13e-0536827876312
Pubmed

Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.

RYR1 RYR2

1.13e-05368221881589
Pubmed

Dendritic differentiation of cerebellar Purkinje cells is promoted by ryanodine receptors expressed by Purkinje and granule cells.

RYR1 RYR2

1.13e-05368224123915
Pubmed

Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer.

UGT2B15 UGT2B17

1.13e-05368226385605
Pubmed

Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.

UGT2B15 UGT2B17

1.13e-05368228882566
Pubmed

Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors).

RYR1 RYR2

1.13e-05368212213830
Pubmed

Dopamine D1 receptor signaling system regulates ryanodine receptor expression in ethanol physical dependence.

RYR1 RYR2

1.13e-05368223278119
Pubmed

Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells.

RYR1 RYR2

1.13e-0536829242641
Pubmed

Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.

RYR1 RYR2

1.13e-05368222948152
Pubmed

Direct association of the reticulon protein RTN1A with the ryanodine receptor 2 in neurons.

RYR1 RYR2

1.13e-05368223454728
Pubmed

Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.

RYR1 RYR2

1.13e-05368210788707
Pubmed

Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells.

UGT2B15 UGT2B17

1.13e-05368217988216
Pubmed

Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.

RYR1 RYR2

1.13e-05368225239916
Pubmed

Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.

RYR1 RYR2

1.13e-0536827621815
Pubmed

A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.

RYR1 RYR2

1.13e-05368218643873
Pubmed

Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).

RYR1 RYR2

1.13e-05368211159936
Pubmed

Tissue distribution and relative gene expression of UDP-glucuronosyltransferases (2B7, 2B15, 2B17) in the human fetus.

UGT2B15 UGT2B17

1.13e-05368223223495
Pubmed

Intracellular calcium release channel expression during embryogenesis.

RYR1 RYR2

1.13e-0536829986730
Pubmed

Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes.

UGT2B15 UGT2B17

1.13e-05368218302198
Pubmed

The nuclear receptor Shp regulates morphine withdrawal syndrome via modulation of Ugt2b expression in mice.

UGT2B15 UGT2B17

1.13e-05368230689982
Pubmed

Molecular identification of the ryanodine receptor pore-forming segment.

RYR1 RYR2

1.13e-05368210473538
Pubmed

Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.

RYR1 RYR2

1.13e-0536827959768
Pubmed

The organization of proteins in the human red blood cell membrane. A review.

RYR1 RYR2

1.13e-0536824600883
Pubmed

Regulation of mouse egg activation: presence of ryanodine receptors and effects of microinjected ryanodine and cyclic ADP ribose on uninseminated and inseminated eggs.

RYR1 RYR2

1.13e-0536827635066
Pubmed

A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.

RYR1 RYR2

2.25e-05468218206662
Pubmed

Increase of ryanodine receptors by dopamine D1 receptors is negatively regulated by γ-aminobutyric acid type B receptors in primary cultures of mouse cerebral cortical neurons.

RYR1 RYR2

2.25e-05468222504960
Pubmed

Calmodulin modulates the termination threshold for cardiac ryanodine receptor-mediated Ca2+ release.

RYR1 RYR2

2.25e-05468223992453
Pubmed

Ryanodine receptor calcium release channels: lessons from structure-function studies.

RYR1 RYR2

2.25e-05468223413940
Pubmed

Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles.

RYR1 RYR2

2.25e-0546829384575
Pubmed

Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.

RYR1 RYR2

2.25e-0546829607712
Pubmed

S100A1 Protein Does Not Compete with Calmodulin for Ryanodine Receptor Binding but Structurally Alters the Ryanodine Receptor·Calmodulin Complex.

RYR1 RYR2

2.25e-05468227226555
Pubmed

Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells.

UGT2B15 UGT2B17

2.25e-05468218281521
Pubmed

Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.

UGT2B15 UGT2B17

2.25e-05468226176234
Pubmed

Hypoxia differently modulates gene expression of inositol 1,4,5-trisphosphate receptors in mouse kidney and HEK 293 cell line.

RYR1 RYR2

2.25e-05468219120137
Pubmed

FKBP binding characteristics of cardiac microsomes from diverse vertebrates.

RYR1 RYR2

2.25e-05468211237759
Pubmed

Conserved and divergent functions of Nfix in skeletal muscle development during vertebrate evolution.

RYR1 RYR2

2.25e-05468223482488
Pubmed

Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.

VIPR1 TSC2 HTR3B ARHGAP35 SDC2 CHRNB3

2.74e-0530068619086053
Pubmed

Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction.

RYR1 RYR2

3.75e-05568222939628
Pubmed

Intracellular calcium-release channels: regulators of cell life and death.

RYR1 RYR2

3.75e-0556829124414
Pubmed

Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons.

RYR1 RYR2

3.75e-05568223918386
Pubmed

Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells.

RYR1 RYR2

3.75e-05568219011160
Pubmed

Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins.

ESYT2 RETREG2 MBOAT7 WFS1 PIEZO1 ARHGAP35 GPAT4

5.47e-0549968722810586
Pubmed

Membrane depolarization causes a direct activation of G protein-coupled receptors leading to local Ca2+ release in smooth muscle.

RYR1 RYR2

5.62e-05668219549818
Pubmed

Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos.

RYR1 RYR2

5.62e-05668226025922
Pubmed

Roles of I(f) and intracellular Ca2+ release in spontaneous activity of ventricular cardiomyocytes during murine embryonic development.

RYR1 RYR2

5.62e-05668223463619
Pubmed

FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells.

RYR1 RYR2

5.62e-05668214592808
Pubmed

A calcium-induced calcium release mechanism supports luteinizing hormone-induced testosterone secretion in mouse Leydig cells.

RYR1 RYR2

5.62e-05668220519450
Pubmed

Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging.

RYR1 RYR2

5.62e-05668225966694
Pubmed

HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization.

RYR1 RYR2

5.62e-05668219009018
Pubmed

Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer.

UGT2B15 UGT2B17

5.62e-05668221365123
Pubmed

IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1.

RYR1 RYR2

5.62e-05668216844763
Pubmed

Developmental expression of the calcium release channels during early neurogenesis of the mouse cerebral cortex.

RYR1 RYR2

7.86e-05768211860456
Pubmed

Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.

UGT2B15 UGT2B17

7.86e-05768226074487
Pubmed

Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.

RYR1 RYR2

7.86e-05768220962236
Pubmed

Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.

UGT2B15 UGT2B17

1.05e-04868232093886
Pubmed

Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.

RYR1 RYR2

1.05e-04868219033399
Pubmed

Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry.

UGT2B15 UGT2B17

1.05e-04868222579593
Pubmed

Sequential docking, molecular differentiation, and positioning of T-Tubule/SR junctions in developing mouse skeletal muscle.

RYR1 RYR2

1.05e-04868211784029
Pubmed

The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.

UGT2B15 UGT2B17

1.05e-04868218719240
Pubmed

Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States.

UGT2B15 UGT2B17

1.05e-04868220142249
Pubmed

AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis.

RYR1 RYR2

1.68e-041068218434328
Pubmed

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.

TSC2 RYR1 RYR2

1.94e-045768323788249
Pubmed

Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.

UGT2B15 UGT2B17

2.45e-041268220308471
Pubmed

New molecular components supporting ryanodine receptor-mediated Ca(2+) release: roles of junctophilin and TRIC channel in embryonic cardiomyocytes.

RYR1 RYR2

2.45e-041268219095005
Pubmed

Brn3a and Nurr1 mediate a gene regulatory pathway for habenula development.

SCN8A RTN4RL2 SDC2 CHRNB3

3.21e-0416668419906978
Pubmed

A directed protein interaction network for investigating intracellular signal transduction.

TMX2 RETREG2 SBF1 MBOAT7 WFS1 PDS5A TSC2 NR4A1 SNAPC4

3.32e-04112468921900206
Pubmed

MED12 regulates a transcriptional network of calcium-handling genes in the heart.

RYR1 RYR2

3.38e-041468228724790
InteractionOPALIN interactions

AGPAT5 SBF1 MBOAT7 WFS1 PDS5A TSC2 UBE3C GPAT4

2.78e-07209638int:OPALIN
InteractionSTARD3NL interactions

AGPAT5 MBOAT7 WFS1 GPAT4

2.10e-0552634int:STARD3NL
Cytoband4q13

UGT2B15 UGT2B17

2.31e-04156924q13
Cytoband7q36.3

ESYT2 UBE3C

6.01e-04246927q36.3
GeneFamilyRyanodine receptors|Protein phosphatase 1 regulatory subunits

RYR1 RYR2

2.34e-053512287
GeneFamily1-acylglycerol-3-phosphate O-acyltransferases

AGPAT5 GPAT4

4.22e-041151246
DrugRyanodine

NR4A1 RYR1 RYR2

5.50e-0612683ctd:D012433
Drug(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; PC3; HT_HG-U133A

ABCG4 CXCR3 ATP9B HTR3B HSD17B1 RYR1

1.74e-051826866663_UP
DrugAndrostane-3,17-diol

UGT2B15 UGT2B17 NR1I3

2.01e-0518683ctd:D015113
Drug2-hydroxycarbazole

RYR1 RYR2

2.63e-053682CID000093551
Drugcis-diammineplatinum(II

RYR1 RYR2

2.63e-053682CID000159790
Drug2-hydroxyheptanoic acid

RYR1 RYR2

2.63e-053682CID002750949
DrugRyanodyl 3-(pyridine-3-carboxylate

RYR1 RYR2

2.63e-053682CID005748312
Drug8N3-cADPR

RYR1 RYR2

2.63e-053682CID000127713
Drugaminodantrolene

RYR1 RYR2

2.63e-053682CID009570289
DrugMK-886; Down 200; 1uM; MCF7; HG-U133A

ABCG4 VIPR1 SBF1 PDS5A TMEM39A NR4A1

2.72e-05197686601_DN
Drug2,2',3,5',6-pentachlorobiphenyl

NR1I3 RYR1 RYR2

2.80e-0520683ctd:C032904
DrugPiribedil hydrochloride [78213-63-5]; Up 200; 12uM; PC3; HT_HG-U133A

SBF1 KCND3 HSD17B1 ARHGAP35 SDC2 RYR2

2.97e-052006866333_UP
DrugPCB74

RYR1 RYR2

5.25e-054682CID000036218
Drug148504-47-6

RYR1 RYR2

5.25e-054682CID006444275
DrugSC 38249

RYR1 RYR2

5.25e-054682CID000134834
DrugAC1L1U7A

RYR1 RYR2

5.25e-054682CID000035682
Diseasecongenital myopathy 1A (implicated_via_orthology)

RYR1 RYR2

1.39e-053642DOID:3529 (implicated_via_orthology)
Diseasemalignant hyperthermia (implicated_via_orthology)

RYR1 RYR2

1.39e-053642DOID:8545 (implicated_via_orthology)
Diseasecholic acid glucuronide measurement

UGT2B15 UGT2B17

1.39e-053642EFO_0800574
DiseaseX-25937 measurement

UGT2B15 UGT2B17

2.77e-054642EFO_0800937
DiseaseX-24574 measurement

UGT2B15 UGT2B17

9.66e-057642EFO_0800897
Diseasedeoxycholic acid glucuronide measurement

UGT2B15 UGT2B17

1.29e-048642EFO_0800575
Diseaseobsolete_red blood cell distribution width

GPR158 HECW2 PIEZO1 TMC8 UGT2B15 SLC15A5 PDS5A AK9 TIPRL NR1I3 CHRNB3

1.38e-0413476411EFO_0005192
Disease4-androsten-3alpha,17alpha-diol monosulfate (3) measurement

UGT2B15 UGT2B17

2.06e-0410642EFO_0022090
DiseaseDNA repair protein RAD51 homolog 4 measurement

UGT2B15 UGT2B17

2.52e-0411642EFO_0801531
Disease5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement

UGT2B15 UGT2B17

3.01e-0412642EFO_0800291
Diseaseandrostenediol (3alpha, 17alpha) monosulfate (3) measurement

UGT2B15 UGT2B17

3.56e-0413642EFO_0800293
DiseaseX-19141 measurement

UGT2B15 UGT2B17

3.56e-0413642EFO_0800799
Disease5alpha-androstan-3alpha,17alpha-diol monosulfate measurement

UGT2B15 UGT2B17

4.14e-0414642EFO_0800283
Diseasedepressive disorder (is_implicated_in)

HTR3B CHRNB3

6.17e-0417642DOID:1596 (is_implicated_in)
Diseasesweet liking measurement

KISS1R TMEM63C

6.93e-0418642EFO_0010156
Disease5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement

UGT2B15 UGT2B17

6.93e-0418642EFO_0800288
Diseaseetiocholanolone glucuronide measurement

UGT2B15 UGT2B17

7.73e-0419642EFO_0800362
Diseaseandrosterone glucuronide measurement

UGT2B15 UGT2B17

8.58e-0420642EFO_0800317
Diseasealcohol use disorder (implicated_via_orthology)

VIPR1 RYR1 CHRNB3 RYR2

8.62e-04195644DOID:1574 (implicated_via_orthology)
DiseaseX-24947 measurement

UGT2B15 UGT2B17

1.04e-0322642EFO_0800910
Diseaselymphocyte count, response to vaccine

HECW2 PXMP2

1.04e-0322642EFO_0004587, EFO_0004645
DiseaseWest Syndrome

PIGA TSC2

1.24e-0324642C0037769
Diseasemetabolite measurement

MBOAT7 PXMP2 UGT2B15 UGT2B17 WDFY4 SLC36A2

1.34e-03560646EFO_0004725
Diseaseepiandrosterone sulfate measurement

UGT2B15 UGT2B17

1.35e-0325642EFO_0021120
Diseaseobsessive-compulsive symptom measurement

TMTC1 TMEM63C

2.07e-0331642EFO_0007802

Protein segments in the cluster

PeptideGeneStartEntry
FDRAFLPALYSLLFL

CXCR3

51

P49682
LARSFALLLPVYALG

ESYT2

116

A0FGR8
SFVLRRLPLFYTLFL

CHRNB3

226

Q05901
LVLGIFFLALRLLAY

ABCG4

621

Q9H172
LVLLSRFDRLLFQSY

HTR3B

406

O95264
YFLGFLLLAARLPLD

GPNMB

6

Q14956
LFEYRARRFLSLPST

CAMTA2

611

O94983
RARLGLYIFARVSLF

AQR

1296

O60306
LQRFYHRLLRPLSLF

CCDC87

11

Q9NVE4
PRRSLLAALFFFSLS

B4GALT5

11

O43286
AAFRGLSRLTILYLF

RTN4RL2

221

Q86UN3
YLPLALHLASEFFLR

PDS5A

66

Q29RF7
LLRIPAFSRDLYLLL

ADAMTS19

166

Q8TE59
RRPLFRSCFILLPYL

TIPARP

401

Q7Z3E1
SAFLELFILRLAYRS

NR4A1

441

P22736
AFFTRPFYKALLRIL

HECW2

1326

Q9P2P5
RPRDRFLYAKLLGLL

NR1I3

306

Q14994
ILLLPFLAILASYAR

OR2AK2

221

Q8NG84
YLLRLFAAPSRYRFI

KCND3

241

Q9UK17
ILYFEPSTFRCILLR

GPR158

471

Q5T848
RFLLLFSYIIPISLR

ATP9B

411

O43861
RPLLLLAYFSRLCAK

IL17RE

586

Q8NFR9
LLRLGSLFCYSTRLF

TMEM63C

561

Q9P1W3
RELQPFLFLTFSLLY

OR4K15

21

Q8NH41
PSRALERAFALYNLL

KISS1R

196

Q969F8
SYLLFFRALSLLGLP

MBOAT7

81

Q96N66
CRGLLALLFPLRYSF

SBF1

251

O95248
RPLFVLFLLLYVASL

OR1K1

26

Q8NGR3
LEAVRLPFVRRFYLL

KLHL21

221

Q9UJP4
RYCFLLPLRIALAFT

GPAT4

171

Q86UL3
LPLQRSAARLLFSFY

FCRLA

196

Q7L513
TLRYFTTERFLPLLR

HSD17B1

251

P14061
RLLLYVRASPLFYES

IDI2-AS1

91

Q9NZ38
ASRALRLAPFVYLLL

HEPACAM

11

Q14CZ8
GFLFAIFLILLLVYR

SDC2

156

P34741
FLTLLPLFIFQLLYR

SLC15A5

306

A6NIM6
LSRNFYTLRFLALFL

RYR1

4556

P21817
TLARDLYAFYPLLIR

RYR2

3361

Q92736
FPFLSIRRSALLYIA

AK9

1826

Q5TCS8
LSLRYDLTVPFARYL

HARS2

126

P49590
LRPFFLLSVSLLAYF

RETREG2

101

Q8NC44
FGLAALYAPVLLLRA

SFT2D3

91

Q587I9
LYAPVLLLRARKFAL

SFT2D3

96

Q587I9
SRLYMLSFLPFLVLL

SLC36A2

201

Q495M3
ILLFLAFLLLFLYRR

SMIM28

61

A0A1B0GU29
EFLLSLRYFRIFIAL

SMIM7

46

Q9BQ49
LYLKFRLPEISRFSA

PROS1

311

P07225
RRKLYLAALPLAFEA

ARHGAP35

336

Q9NRY4
NRRVLYAATFLLFPL

STRA6

506

Q9BX79
LCYLLLPATRLFRAL

ANGEL1

6

Q9UNK9
LFHSLPLLRYIFVRE

PIGA

106

P37287
YLLSALLSAAFLLVR

TMX2

26

Q9Y320
YSRLARSTLLLIPLF

VIPR1

336

P32241
IRSYFTFLRFLLLLN

TMC8

106

Q8IU68
LACLLFLLAFLSYNR

TMTC1

171

Q8IUR5
ALPRRALAQYLLFLR

PXMP2

16

Q9NR77
PSSFFLLLRFFLRID

TIPRL

176

O75663
YFLFHRPLRLLNLLI

TMEM39A

411

Q9NV64
PCYLILTLLRFSFDL

USP35

801

Q9P2H5
LLLYFLASPSLRTRF

WDFY4

1646

Q6ZS81
ALYILSPFNLIRRIA

SCN8A

111

Q9UQD0
YLLLRARFLAAFTLP

SNAPC4

1361

Q5SXM2
RFSGLSLVYLLFLLL

PIEZO1

26

Q92508
LAELFNIPFLYSLRF

UGT2B15

161

P54855
RLLSAFLPARFYQAL

AGPAT5

36

Q9NUQ2
LAELLNIPFLYSLRF

UGT2B17

161

O75795
FLSTLARLPHLYRNF

TSC2

846

P49815
PKVRLLYSLAFNARF

UBE3C

441

Q15386
VYSPLALRRLTAFLE

ZAR1

181

Q86SH2
LLRASIGYFLFLFAL

WFS1

556

O76024